. home.aspx

home.aspx
   

The 10 latest FDA Orphan Drug Designations for cancer treatments

September 25, 2019 / VICTORIA REES

The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions. The US Food and Drug Administration’s (FDA) Orphan Drug Designation (ODD) denotes medications that are potential promising treatments for rare diseases in their R&D stages. Here, we list the 10 most recent ODDs granted to therapies indicated for cancers, with the newest first.